glp 1 oral supplements FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions GLP-1 Supplement

This paradigm shift could have major public health implications, addressing the massive treatment gap in AUD by providing an option for those who do not necessarily identify as having an AUD but still engage in hazardous alcohol use

Supplementary Materials Data Availability Statement The data that support the findings of this study are available from Centers for Medicare & Medicaid Services (CMS), but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available

Novo Nordisk is running two phase 3 clinical trials that will compare semaglutide to a placebo in more than 3,000 patients with mild cognitive impairment or early-stage Alzheimers disease

59 Table 3

Krajnc N, Itariu B, Macher S, et al